Bosh sahifaSNPHY • OTCMKTS
add
Santen Pharmaceutical ADR Representing Ord Shs
Yopilish kursi
8,81 $
Kunlik diapazon
8,75 $ - 9,53 $
Yillik diapazon
8,65 $ - 13,00 $
Bozor kapitalizatsiyasi
479,79 mlrd JPY
Oʻrtacha hajm
16,56 ming
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (JPY) | dek, 2024info | Y/Y qiyosi |
|---|---|---|
Daromad | 76,37 mlrd | -0,85% |
Joriy xarajat | 30,91 mlrd | -8,61% |
Sof foyda | 8,69 mlrd | 18,56% |
Sof foyda marjasi | 11,38 | 19,54% |
Har bir ulushga tushum | — | — |
EBITDA | 15,83 mlrd | 0,55% |
Amaldagi soliq stavkasi | 24,64% | — |
Balans
Jami aktivlari
Jami passivlari
| (JPY) | dek, 2024info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 77,85 mlrd | -5,09% |
Jami aktivlari | 398,31 mlrd | -6,90% |
Jami passivlari | 115,10 mlrd | -11,35% |
Umumiy kapital | 283,21 mlrd | — |
Tarqatilgan aksiyalar | 341,35 mln | — |
Narxi/balansdagi bahosi | 0,01 | — |
Aktivlardan daromad | 7,01% | — |
Kapitaldan daromad | 9,91% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (JPY) | dek, 2024info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 8,69 mlrd | 18,56% |
Operatsiyalardan naqd pul | 13,73 mlrd | -56,70% |
Sarmoyadan naqd pul | -2,77 mlrd | -42,37% |
Moliyadan naqd pul | -20,22 mlrd | -73,43% |
Naqd pulning sof oʻzgarishi | -6,59 mlrd | -138,09% |
Boʻsh pul | 9,01 mlrd | -68,47% |
Haqida
Santen Pharmaceutical Co., Ltd., is a Japanese pharmaceutical company, specializing in ophthalmology. With its ophthalmic products Santen holds the top share within the Japanese market and is one of the leading ophthalmic companies worldwide, with its products being sold in over 50 countries.
The company was founded in 1890 by Kenkichi Taguchi, as Taguchi Santendo, and in 1925, Santendo Co., Ltd. was established. In 2014 Santen announced that it has entered into an agreement with Merck & Co. to purchase Merck's ophthalmology products. Wikipedia
Tashkil etilgan
1890
Bosh ofis
Sayt
Xodimlar soni
3 744
